Stock Information
Charles River Laboratories International Inc (CRL)
Ticker Symbol: CRL
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $8,558.08 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -2.9563
Revenue (TTM): $81.59 M
Dividend Yield: N/A%
ROE: -4.4%
Latest News
-
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Thu, Apr 30, 2026 2:00 PM
-
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
Thu, Apr 30, 2026 12:00 PM
-
Middle East and Africa Cell and Gene Therapy Manufacturing Market Report 2026 Featuring Catalent, Charles River Labs, Lonza, Merck, Thermo Fisher Scientific, and WuXi AppTec
Wed, Apr 29, 2026 3:33 PM
-
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock
Tue, Apr 28, 2026 1:40 PM
Key Financials
Financial data not available
